Elizabeth Luttrell Williams serves as Vice President - Manufacturing Operations of the Company. Previously, she led the U.S. Region for Zoetis as Vice President, Global Manufacturing and Supply. Prior to that, she held multiple Site Leader positions at Pfizer Animal Health facilities in Lincoln, Nebraska (2008-2011), Conshohocken, Pennsylvania (2006-2008) and Lee’s Summit, Missouri (2003-2006). She led the manufacturing organization (1999-2003) and the Process and Product Development group (1995-1999), achieving registration, approval and successful scale-up of five new products at the Lee’s Summit facility. She earned her Masters of Business Administration from Rockhurst University in Kansas City, Missouri and her Bachelor’s degree in Biology from the University of Missouri.
As the Vice President - Manufacturing Operations of Immucell, the total compensation of Elizabeth Williams at Immucell is $278,494. There are 3 executives at Immucell getting paid more, with Michael F. Brigham having the highest compensation of $354,272.
Elizabeth Williams is 63, she's been the Vice President - Manufacturing Operations of Immucell since 2016. There are 4 older and 6 younger executives at Immucell. The oldest executive at Immucell Corp. is Jonathan Rothschild, 66, who is the Independent Director.
Elizabeth's mailing address filed with the SEC is 56 Evergreen Dr, Portland, ME 04103, USA.
Over the last 21 years, insiders at Immucell have traded over $168,227 worth of Immucell stock and bought 568,684 units worth $2,330,117 . The most active insiders traders include Jonathan E Rothschild, Norman H Pessin und Joseph H Crabb. On average, Immucell executives and independent directors trade stock every 50 days with the average trade being worth of $22,979. The most recent stock trade was executed by David Cunningham on 13 June 2022, trading 1,000 units of ICCC stock currently worth $8,000.
immucell corporation is a biotechnology company based out of portland maine. immucell's focus is to create scientifically-proven and practical products that result in a measurable economical impact on animal health and productivity in the dairy and beed industries.
Immucell executives and other stock owners filed with the SEC include: